US20140081317A1 - Removable medical device implantable in blood vessels, particularly in the thoracic aorta with aneurysm - Google Patents

Removable medical device implantable in blood vessels, particularly in the thoracic aorta with aneurysm Download PDF

Info

Publication number
US20140081317A1
US20140081317A1 US14/116,021 US201214116021A US2014081317A1 US 20140081317 A1 US20140081317 A1 US 20140081317A1 US 201214116021 A US201214116021 A US 201214116021A US 2014081317 A1 US2014081317 A1 US 2014081317A1
Authority
US
United States
Prior art keywords
duct
medical device
implantable medical
aneurysm
radial dimension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/116,021
Other languages
English (en)
Inventor
Paolo Zanatta
Fabrizio Farneri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Be Safe Srl
Original Assignee
Paolo Zanatta
Fabrizio Farneri
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paolo Zanatta, Fabrizio Farneri filed Critical Paolo Zanatta
Publication of US20140081317A1 publication Critical patent/US20140081317A1/en
Assigned to BE SAFE SRL reassignment BE SAFE SRL ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FARNETI, Fabrizio, ZANATTA, Paolo
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/07—Stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/07—Stent-grafts
    • A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9528—Instruments specially adapted for placement or removal of stents or stent-grafts for retrieval of stents

Definitions

  • the present invention relates to a removable implantable medical device in blood vessels, particularly for implantation in the thoracic aorta affected by aneurysm.
  • An aneurysm is a pathology that manifests itself as a variable and non-reversible dilation of a blood vessel.
  • Thoracic Aortic Aneurysm is a dilation of the thoracic aorta.
  • An aneurysm is a pathology that develops progressively in that at every dilation of the wall of the vessel there is a corresponding increase in the radial tension acting on the wall and thus a further action of expansion on the vessel.
  • This pathology is treated by administering pharmaceuticals or, in more serious cases, by surgery, the latter being particularly recommended for aneurysms larger than 6 centimeters.
  • Surgery to treat an aneurysm substantially consists of surgical prosthetic substitution with thoracotomic and laparotomic access of an aortic segment, with sequential clamping and reimplantation of collateral arteries.
  • An alternative method of surgical treatment to the conventional method uses endovascular techniques, which make it possible for the aneurysm to be covered by positioning a vascular endoprosthesis, which is substantially a synthetic duct that is adapted to functionally substitute the portion of vessel affected by aneurysm.
  • a vascular endoprosthesis which is substantially a synthetic duct that is adapted to functionally substitute the portion of vessel affected by aneurysm.
  • a “new lumen” for blood circulation is created which prevents the blood flow from exerting a pressure on the deformed walls that surround the aneurysm.
  • the blood in the pockets defined between the outer walls of the vascular prosthesis and the deformed walls of the blood vessel is not subjected to any pressure force and rapidly coagulates.
  • neurophysiological parameters relating to the medullary function are read, and in particular the descending motor nerve pathways and ascending somatosensory nerve pathways are monitored.
  • an intraoperative therapy is immediately begun to improve the perfusion of the spinal cord, which essentially consists of increasing the availability of oxygen to the spinal cord, so as to increase the arterial pressure, the cardiac flow-rate, the concentration of hemoglobin, the saturation of oxygen and reduce the endoliquoral pressure. If this therapy is not sufficient to re-establish the medullary function, the surgeon will anastomize the intercostal vessels that were sacrificed during surgery so as to restore collateral circulation in order to get the blood to the spinal cord.
  • the only possible solution is to resort to medical therapy (increase spinal perfusion pressure, by increasing arterial pressure, cardiac flow rate and reducing liquoral pressure).
  • aneurysms particularly of aneurysms of the thoracic aorta
  • endovascular prostheses the need is particularly felt to assess the risks of onset of ischemic suffering before the definitive implantation of the endovascular prosthesis. More specifically, for thoracic aortic aneurysms, it is necessary to test whether the grafting of the endovascular prosthesis can cause the arrest of the blood flow in the vessels that supply the spinal cord.
  • the techniques currently developed to achieve this aim use endovascular devices that cause the blocking of the intercostal arteries and of the aorta so as to evaluate the response of the organism by monitoring the evoked potentials of the spinal cord.
  • blocking the aortic portion in which the aneurysm is present is simulated by inserting two balloons at the two ends of the aneurysm itself.
  • U.S. 2005/0131515, U.S. 2009/0171441 and WO 2008/016578 describe prostheses of the definitive type, i.e. prostheses that are not capable of blocking the collateral vessels of the aorta only temporarily, so as to be able to be used in an emergency in acute aortic syndromes, awaiting a definitive prosthesis.
  • the prostheses in the cited prior art documents while being removable, are not capable of provisionally simulating the operation of a definitive prosthesis, in that they are designed as prostheses for therapeutic use and not for preventive and diagnostic use. Moreover it is not possible for such devices to be removable if they are the cause of a medullary ischemia previously detected in the operating theater with adapted monitoring methods.
  • U.S. 2005/0131515 differs furthermore in the absence of a lumen for guiding, the impossibility of varying the prosthetic caliber inside the vessel, the necessity for prework before the implantation (see heating of the prosthesis), and the impossibility of positioning following removal.
  • U.S. 2009/0171441 differs in that it is constituted by a plurality of separate units and in the impossibility of varying the prosthetic caliber inside the vessel.
  • WO 2008/016578 differs in that it can be repositioned only during the procedure. Once released in the position and with the diameter adjusted it is not removable.
  • the aim of the present invention is to provide a device for verifying the arrest of the blood flow in blood vessels during the endovascular treatment of aneurysms.
  • an object of the invention is to provide a device that does not cause blocking of the vessel.
  • Another object of the invention is to provide a device that does not necessitate means for extracorporeal circulation of the blood.
  • an object of the present invention is to provide a device that is highly biocompatible.
  • the present invention sets out to provide an implantable device that can be easily inserted in the vessel and which can be precisely arranged at the portion affected by aneurysm.
  • the present invention sets out to provide an implantable medical device that is compatible with the techniques and instruments normally and usually used for the endovascular treatment of aneurysm.
  • Another object of the invention is to provide a device that is highly reliable, easy to implement and low cost.
  • an implantable and removable medical device for the endovascular treatment of aneurysm particularly of aneurysm of the thoracic aorta
  • a supporting structure which has a substantially tubular shape and is covered externally by a covering, to define a duct for blood circulation, characterized in that it comprises extraction means for extracting said duct from the body of the subject in whom it is inserted, said extraction means being associated with said duct and communicating with the outside of said body.
  • FIG. 1 is a perspective view of an implantable medical device according to the invention
  • FIG. 2 is a schematic diagram of the implantable medical device, according to the invention, positioned in the blood vessel with the aneurysm;
  • FIG. 3 is a schematic diagram of the medical device according to the invention in the extraction configuration.
  • the implantable device according to the invention which can be used during the procedure for the endovascular treatment of aneurysm, particularly of aneurysm of the thoracic aorta, comprises a supporting structure 2 which has a substantially tubular shape and is covered externally by a covering 3 .
  • the supporting structure 2 and its covering 3 define a duct 4 for blood circulation, and in particular this duct substitutes the deformed portion of vessel so as to create a “new lumen” that allows blood circulation within it and does not arrest the blood flow.
  • the peculiarity of the device 1 according to the invention consists in that it comprises extraction means 5 for extracting the device from the body of the subject undergoing the surgery. The extraction occurs by sliding the device 1 through the blood vessels until it is completely outside 6 the body.
  • the extraction means 5 are associated with the duct 4 of the device 1 and they communicate with the outside 6 of the body.
  • the extraction means 5 are a cable 51 within which it is possible to slide an angiographic guide wire 53 , which exits from the end 56 made of biocompatible material connected with the duct 4 .
  • the cable 51 passes through the duct 4 internally along its principal direction of extension, exiting by a few centimeters, thus allowing the free travel of the angiographic guide wire 53 .
  • wires 54 which extend along the entire body of the duct 4 .
  • the wires 54 continue in two cords, respectively 55 a and 55 b , which are directed toward the inside of the radial cross-section of the duct 4 and which join at a point of attachment, respectively 56 a and 56 b , with the cable 51 .
  • the cords 55 make it possible to associate the duct 4 with the cable 51 , which in operational terms constitutes the means of extraction of the duct 4 from the body, i.e. it is the means that functionally makes it possible to obtain the sliding of the duct 4 inside the blood vessels.
  • the duct 4 is positioned inside the blood vessel 100 at the walls 101 deformed by the aneurysm.
  • the length of the duct 4 along its principal direction of extension is greater than the length of the portion of vessel 100 deformed by the aneurysm.
  • the device 1 defines a passage channel for the blood which is defined inside the vessel 100 itself and especially it completely prevents the blood from entering the pockets 104 that form between the deformed walls 101 of the vessel 100 and the outer wall of the duct 4 .
  • the blood that stays locked in the pockets 104 following the grafting of the duct 4 rapidly coagulates.
  • the supporting structure 2 is a meshed fabric, for example it is a net of wires 21 that are interleaved in a zigzag pattern.
  • the wires 21 which constitute the supporting structure 2 are made of biocompatible metallic material, preferably stainless steel or alloys of nickel and titanium, better known as “nitinol”.
  • Nitinol alloys are particularly adapted for this application because they are shape-memory materials, for their ability to adapt to considerable tensions and because they have a high level of physiological and chemical compatibility with the human body.
  • the covering 3 is made of biocompatible polymeric material, such as for example Dacron® or PTFE, or it can be a biological material, of animal or human origin, pharmacologically and chemically treated.
  • the covering 3 is sewn onto the zigzag wires 21 that constitute the supporting structure 2 .
  • the medical device 1 assumes a compressed configuration 41 b and an active configuration 41 a , which is the configuration that the duct 4 assumes when it is positioned at the aneurysm.
  • the duct 4 has a first radial dimension 43 b which is smaller than a second radial dimension 43 a of the duct 4 in the active configuration 41 a.
  • the compressed configuration 41 b is obtained by way of compression of the duct 4 inside a sheath 70 of a catheter 7 that has a diameter 71 which is smaller than that of the duct 4 in its active configuration 41 a.
  • the compression of the duct 4 inside the catheter 7 is obtainable thanks to the elasticity of the material defining the supporting structure 2 .
  • the compressed configuration 41 b obtained when the device 1 is inserted in the catheter 7 is necessary during the step of insertion of the device 1 in the blood vessel 100 .
  • the catheter 7 is inserted in the body and is made to pass through blood vessels until it arrives proximate to the portion of vessel 100 that is deformed by aneurysm. Subsequently the device 1 is inserted in the catheter 7 and assumes its compressed configuration 41 b . The operator, acting on the cable 51 , makes the device 1 advance inside the catheter 7 until it reaches the end tip 72 of the catheter 7 by making it slide in safety in the guide which was previously positioned in the aorta and which functions as a “rail”.
  • the device 1 exiting from the containment sheath 70 defined by the catheter 7 , is positioned at the aneurysm, and expands to assume an active configuration 41 a , which is characterized in that it has a second radial dimension 43 a which is greater than the first radial dimension 43 b assumed by the duct 4 in the compressed configuration 41 b.
  • the extraction means 5 activate an extraction configuration 41 c in which the duct 4 assumes a third radial dimension 43 c which is smaller than the first radial dimension 43 b assumed in the active configuration 41 a.
  • the third radial dimension 43 c is smaller than the diameter of the blood vessel in which it is implanted and also of the vessels that it must pass through in order to arrive outside 6 the body of the subject.
  • the third radial dimension 43 c is substantially equal to that 41 a assumed in the compressed configuration 41 b so as to enable the device to be reinserted in the catheter 7 at the end tip 72 and slide inside the latter until it arrives outside 6 the body.
  • the implantable medical device 1 can be extracted outside 6 body without damaging the interior of the blood vessel or vessels during the passage through them.
  • the duct is elongated along its principal direction of extension and is contracted radially, until it assumes the extraction configuration 41 c.
  • the means 5 of extracting the device 1 are activated after the detection, by way of detection electrodes (not shown in the accompanying figures) of evoked potentials generated in response to a stimulation achieved by way of stimulation electrodes.
  • the catheter 7 is inserted through the femoral artery, from where it is made to ascend to the aorta and halt proximate to the portion of vessel 100 deformed by aneurysm.
  • the device 1 is inserted in the catheter 7 , which, assuming its compressed configuration 41 b , is pushed into the catheter 7 until it reaches the end tip 72 thereof.
  • the end 52 of the cable 51 that constitutes the extraction means 5 remains outside 6 the body of the subject in whom the device 1 is inserted. Specifically, it exits at the point where the incision necessary for the insertion of the catheter 7 was made.
  • the device 1 exiting from the end tip 72 of the catheter 7 , expands at the portion affected by aneurysm.
  • the device 1 assuming its active configuration 41 a , substitutes the walls of the vessel 100 affected by aneurysm by defining a duct 4 for blood circulation and blocking the entry of blood into the pockets 104 .
  • neurophysiological monitoring can be carried out of the functions of the spinal cord in order to evaluate whether the insertion of the device 1 has caused the blocking of blood vessels that supply the spinal cord.
  • Such monitoring can be performed by way of an adapted apparatus, generally constituted by stimulators and amplifiers connected to a processor and a screen for displaying traces of somatosensory and motor potentials.
  • Somatosensory potentials are electrical signals detected on the scalp of the patient at the somatosensory cortex. They derive from the repetitive stimulation at a certain frequency and power of a peripheral nerve, such as the rear tibial nerve. The stimulation applied in the region of the ankle is recorded at the popliteus and then at the lumbar and cervical regions and finally in the cortex.
  • the motor potentials are obtained following high-intensity external stimuli applied to the scalp at the motor cortex and by recording the muscular contraction in the peripheral region, in the feet and legs.
  • the high-intensity stimulation has the drawback of causing small muscular jolts, which could make the procedure less easy.
  • the introduction into the femoral artery can be responsible for ischemia in the corresponding lower limb thus rendering the monitoring of the motor and somatosensory pathway unusable on that side.
  • an alternative is the low-energy stimulation of the motor cortex and detection of the response of the corticospinal motor pathways in the spinal cord, under the presumed bodily location of injury, by way of an electrocatheter inserted previously in the epidural space.
  • the evoked potential that is generated in the spinal cord (D wave), corresponding to the activation of the descending corticospinal fascicle, also has the advantage of not being depressed in the presence of muscle relaxants, and moreover it provides important prognostic information (the absence of the muscle motor potential but the persistence of the D wave are indicative of a good outcome in the long term while only the concomitant absence of the D wave and of the motor potential are indicative of negative outcomes with paraplegia).
  • the epidural electrocatheter would make it possible to explore the somatosensory pathway by epidural electrical stimulation if it is not possible to stimulate the rear tibial nerve owing to ischemia of the lower limb.
  • the means of extracting the device are activated, which make the device 1 assume the extraction configuration 41 c in order to allow the removal by sliding within the vessels without damaging their intima.
  • the cable 51 is held by the operator at the end 52 outside 6 the body of the subject in whom the device 1 is implanted, and it is gently pulled in the direction of extraction 57 so as to make it slide inside the vessels until the duct 4 is completely outside 6 the body of the subject in whom it had been implanted.
  • the specialist can evaluate whether the implanting of the device 1 has caused the onset of ischemic suffering as a consequence of its presence at the portion of vessel 100 affected by aneurysm.
  • the specialist decides whether to treat the aneurysm by way of inserting a definitive endovascular prosthesis (and to evaluate the extension thereof) or whether to opt for other methods of intervention.
  • the device according to the invention fully achieves the intended aim in that it makes it possible to verify the arrest of the blood flow in blood vessels in the endovascular treatment of aneurysm.
  • the device comprises a tubular-shaped support covered by a covering makes it possible to define a duct that allows blood to circulate within it without causing the blocking of the vessel and without necessitating means for extracorporeal circulation.
  • the supporting structure is made of biocompatible metallic material
  • the fact that the covering is made of biocompatible polymeric or biological material and moreover the fact that the cable for extraction is made of biocompatible material, makes it possible to obtain a device that is highly biocompatible overall.
  • the device can assume a compressed configuration enables its insertion and sliding inside a catheter, in this manner facilitating the operation of positioning at the aneurysm.
  • the device can assume an extraction configuration in which the radial dimension is smaller than that assumed in the active configuration makes it possible to make the device slide inside vessels without damaging their intima.
  • the device according to the invention can be used in combination and is compatible with the techniques and instruments normally and usually used for endovascular treatment, such as for example angiographic guide wires and valved catheter introducers.
  • the architectural material used i.e. nitinol, an alloy of nickel and titanium which in opening outside the jacket tends to reach the nominal diameter without appreciable elongation or shortening of the structure in different calibers (this makes it possible to have the exact length in every measurement of the aortic segment to be excluded, and subsequently to have the right length of the definitive prosthesis).
  • the presence of the guide inside the device enables a less traumatic endovascular management of the entire system, in any cranial or caudal movements thereof, and the possibility of shortening passages for the various measurements.
  • Nitinol moreover enables the construction of small caliber systems, with possible percutaneous approach.
  • Such possibility thus also enables the optional monitoring of the patient with functional RM, both in the perioperative period and in preoperative planning if any (locating the great radicular artery in RM with the device positioned).
  • the great radicular artery of Adamkiewicz is the arterial vessel that most greatly affects the perfusion of the spinal cord and it has a variable origin in the abdominal thoracic aorta.
  • the device according to the invention has been conceived in particular for positioning at aneurysms of the thoracic aorta, it can also be used, more generally, for aneurysms present in other blood vessels or in urgent use in rupturing aortic aneurysms (temporary urgent blocking of the aneurysm without arresting flow, as an alternative to clamping in urgent laparotomy or to percutaneous positioning of occluding balloon, while awaiting an open or endovascular surgical solution).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Prostheses (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
US14/116,021 2011-05-10 2012-05-09 Removable medical device implantable in blood vessels, particularly in the thoracic aorta with aneurysm Abandoned US20140081317A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000796A ITMI20110796A1 (it) 2011-05-10 2011-05-10 Dispositivo medico impiantabile rimovibile in vasi sanguigni, particolarmente nell'aorta toracica con aneurisma.
ITMI2011A000796 2011-05-10
PCT/IB2012/052302 WO2012153275A1 (en) 2011-05-10 2012-05-09 Removable medical device implantable in blood vessels, particularly in the thoracic aorta with aneurysm

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2012/052302 A-371-Of-International WO2012153275A1 (en) 2011-05-10 2012-05-09 Removable medical device implantable in blood vessels, particularly in the thoracic aorta with aneurysm

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/656,984 Continuation US10617424B2 (en) 2011-05-10 2017-07-21 Method for testing insurgence of spinal ischemia due to endovascular treatment of aortic aneurisms

Publications (1)

Publication Number Publication Date
US20140081317A1 true US20140081317A1 (en) 2014-03-20

Family

ID=44554465

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/116,021 Abandoned US20140081317A1 (en) 2011-05-10 2012-05-09 Removable medical device implantable in blood vessels, particularly in the thoracic aorta with aneurysm
US15/656,984 Expired - Fee Related US10617424B2 (en) 2011-05-10 2017-07-21 Method for testing insurgence of spinal ischemia due to endovascular treatment of aortic aneurisms

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/656,984 Expired - Fee Related US10617424B2 (en) 2011-05-10 2017-07-21 Method for testing insurgence of spinal ischemia due to endovascular treatment of aortic aneurisms

Country Status (8)

Country Link
US (2) US20140081317A1 (pt)
EP (1) EP2706954B1 (pt)
CN (1) CN103517686A (pt)
BR (1) BR112013028911B1 (pt)
DK (1) DK2706954T3 (pt)
ES (1) ES2613429T3 (pt)
IT (1) ITMI20110796A1 (pt)
WO (1) WO2012153275A1 (pt)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10617424B2 (en) 2011-05-10 2020-04-14 Be Safe Srl Method for testing insurgence of spinal ischemia due to endovascular treatment of aortic aneurisms
US11684497B2 (en) 2017-09-08 2023-06-27 Jotec Gmbh Intraluminal vessel prosthesis system

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10265515B2 (en) * 2015-03-27 2019-04-23 Covidien Lp Galvanically assisted aneurysm treatment
JP6949053B2 (ja) * 2016-05-13 2021-10-13 スイス ファウイクス フェーネンテラピー ウント フォルシュング ゲゼルシャフト ミット ベシュレンクテル ハフツング 血管の一時的閉塞のための非インプラントデバイスおよびその使用
CA3133857A1 (en) 2019-03-20 2020-09-24 inQB8 Medical Technologies, LLC Aortic dissection implant
CN112263362B (zh) * 2020-09-11 2023-09-19 中国人民解放军陆军军医大学第一附属医院 一种可回收覆膜支架

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060041271A1 (en) * 2004-08-20 2006-02-23 Gjalt Bosma Vascular filter with sleeve
US20130297003A1 (en) * 2011-01-13 2013-11-07 Innovia Llc Endoluminal Drug Applicator and Method of Treating Diseased Vessels of the Body

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3645399B2 (ja) * 1997-06-09 2005-05-11 住友金属工業株式会社 血管内ステント
US20050131515A1 (en) * 2003-12-16 2005-06-16 Cully Edward H. Removable stent-graft
AU2007281553B2 (en) * 2006-07-31 2013-09-19 Edwards Lifesciences Cardiaq Llc Sealable endovascular implants and methods for their use
CN101343420B (zh) 2007-07-12 2013-10-16 大连理工大学 一类不对称菁类荧光染料
US8926680B2 (en) * 2007-11-12 2015-01-06 Covidien Lp Aneurysm neck bridging processes with revascularization systems methods and products thereby
US8246672B2 (en) * 2007-12-27 2012-08-21 Cook Medical Technologies Llc Endovascular graft with separately positionable and removable frame units
MX2011002473A (es) * 2008-09-04 2011-08-17 Anders Joensson Dispositivo de proteccion embolica temporal y procedimiento medico para su suministro.
US20110009941A1 (en) * 2009-07-08 2011-01-13 Concentric Medical, Inc. Vascular and bodily duct treatment devices and methods
ITMI20110796A1 (it) 2011-05-10 2012-11-11 Fabrizio Farneti Dispositivo medico impiantabile rimovibile in vasi sanguigni, particolarmente nell'aorta toracica con aneurisma.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060041271A1 (en) * 2004-08-20 2006-02-23 Gjalt Bosma Vascular filter with sleeve
US20130297003A1 (en) * 2011-01-13 2013-11-07 Innovia Llc Endoluminal Drug Applicator and Method of Treating Diseased Vessels of the Body

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10617424B2 (en) 2011-05-10 2020-04-14 Be Safe Srl Method for testing insurgence of spinal ischemia due to endovascular treatment of aortic aneurisms
US11684497B2 (en) 2017-09-08 2023-06-27 Jotec Gmbh Intraluminal vessel prosthesis system

Also Published As

Publication number Publication date
EP2706954B1 (en) 2016-10-12
ITMI20110796A1 (it) 2012-11-11
US20170319215A1 (en) 2017-11-09
CN103517686A (zh) 2014-01-15
US10617424B2 (en) 2020-04-14
WO2012153275A1 (en) 2012-11-15
DK2706954T3 (en) 2017-01-30
BR112013028911B1 (pt) 2020-12-22
ES2613429T3 (es) 2017-05-24
BR112013028911A2 (pt) 2017-01-31
EP2706954A1 (en) 2014-03-19

Similar Documents

Publication Publication Date Title
US10617424B2 (en) Method for testing insurgence of spinal ischemia due to endovascular treatment of aortic aneurisms
JP7445688B2 (ja) 内部トンネルおよび開窓を有するステントグラフトならびに使用の方法
RU2664174C2 (ru) Эндоваскулярный протез и способ доставки эндоваскулярного протеза
US10456168B2 (en) Transmyocardial insertion unit and its use
AU2006272544B2 (en) Devices, systems, and methods for peripheral arteriovenous fistula creation
US8758423B2 (en) Device and method for treating ruptured aneurysms
US8236014B2 (en) Methods for arterio-venous fistula creation
JP6290097B2 (ja) 腔内人工血管
CN104873305B (zh) 术中分支按需阻断式支架型人工血管系统及使用方法
JP2016532491A (ja) 単一体のシステムと装置およびその逆行性灌流利用方法
US8118832B1 (en) Method and apparatus for sealing access
CN107374779A (zh) 一种原位激光动脉开窗装置及其用途
Chen et al. Application of rapid artificial cardiac pacing in thoracic endovascular aortic repair in aged patients
CN217938472U (zh) 主动脉瘤和主动脉夹层治疗用覆膜与裸部混合支架
EP4364780A2 (en) Devices and methods for percutaneous electrode implant
RU195382U1 (ru) Сосудистый эндопротез "мягкий хобот слона" для гибридного лечения расслоения грудной аорты
Pulido et al. Anesthetic considerations for complex endovascular aortic repair
RU2776566C1 (ru) Устройство для фенестрации имплантированного стент-графта
RU196616U1 (ru) Сосудистый эндопротез "мягкий хобот слона" для гибридного лечения расслоения грудной аорты
Sokolowski et al. Basics 21 and Procedures
Wong Congenital Heart Disease-A Review of the Treatment Methods
Yuno et al. Motor-Evoked Potential Monitoring With Multi-train Electrical Stimulation During Thoracoabdominal Aortic Aneurysm Surgery: A Case Report
Husain et al. Thoracic aortic surgery
RU152095U1 (ru) Внутрисосудистый имплантируемый протез нисходящей грудной аорты
Butera et al. Partially uncovered Cheatham platinum-covered stent to treat complex aortic coarctation associated with aortic wall aneurysm

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: BE SAFE SRL, ITALY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZANATTA, PAOLO;FARNETI, FABRIZIO;REEL/FRAME:047559/0924

Effective date: 20181121